Can organophosphate pesticide exposure alter thyroid hormone levels and thyroid function?

An objective, evidence-based assessment of the relationship between organophosphate pesticide exposure and thyroid function is detailed below.

Clinical and epidemiological evidence

Epidemiological cohorts, clinical case series of acute poisoning, and observational studies consistently link exposure to organophosphate (OP) pesticides with altered thyroid function metrics:

• Acute exposure: Patients presenting with acute organophosphate poisoning demonstrate marked shifts in circulating thyroid hormones. Following severe toxicity, transient but significant reductions in total thyroxine ($T_4$) and triiodothyronine ($T_3$) are frequently observed, accompanied by fluctuations in thyroid-stimulating hormone (TSH).
• Chronic and occupational exposure: Chronic occupational exposure among agricultural workers and residents of pesticide-treated areas is associated with systemic endocrine disruption. Biomarkers of OP exposure, such as urinary dialkyl phosphate (DAP) metabolites and specific organophosphate esters (OPEs), correlate with altered serum thyroid hormone profiles. For instance, cohort studies in agricultural regions have shown significant associations between urinary OP metabolite concentrations and depressed free $T_4$ levels, alongside elevated or compensatory TSH levels.
• Variability in response: The clinical presentation of OP-induced thyroid disruption is highly variable. While many studies document a primary hypothyroid-like pattern (characterized by reduced peripheral $T_4$ and $T_3$), other cohorts report subclinical hyperthyroid-like shifts. This variance is driven by differences in the specific OP compounds, exposure levels, chronicity, and individual host factors such as sex and age.

Mechanistic explanations

Organophosphates disrupt thyroid physiology at multiple regulatory nodes along the hypothalamus-pituitary-thyroid (HPT) axis and in peripheral tissues:

• Thyroid follicular damage: Animal models demonstrate that exposure to common OPs, such as chlorpyrifos, causes histopathological changes in the thyroid gland. These changes include follicular cell hyperplasia, colloid depletion, and architectural disruption, which directly impair the gland's synthetic capacity.
• Dysregulated deiodinase activity: OPs modulate the expression and activity of deiodinase enzymes ($DIO1$, $DIO2$, and $DIO3$). Deiodinases are responsible for the peripheral conversion of inactive prohormone $T_4$ to the metabolically active $T_3$ and the clearance of reverse $T_3$ ($rT_3$). Inhibition of $DIO1$ or $DIO2$ by OP exposure impairs local and systemic activation of thyroid hormones, leading to localized tissue hypothyroidism despite normal or near-normal serum levels.
• Hepatic clearance and receptor interference: OPs accelerate the clearance of thyroid hormones by upregulating hepatic glucuronidation pathways (e.g., uridine diphosphate glucuronosyltransferase, or UGT). Additionally, molecular modeling and in vitro assays indicate that certain OPs can act as antagonists at the thyroid hormone receptor (TR), directly blocking target gene transcription.

Bottom line

Scientific evidence robustly supports the association between organophosphate pesticide exposure and altered thyroid hormone levels and function. This endocrine disruption is driven by direct toxicity to thyroid follicular cells, dysregulation of central HPT axis feedback, and altered peripheral thyroid hormone metabolism via the modulation of deiodinase expression and hepatic clearance.